WHO proposal to exempt biosimilar trials to trigger biotech generics boom The proposal, once approved and adopted by member countries, could trigger a bigger interest in developing generic versions of biotech medicines in India. By Joe Mathew
Will NDA’s landslide victory in Maharashtra election boost market sentiment? Here’s what analysts say
Will NDA’s landslide victory in Maharashtra election boost market sentiment? Here’s what analysts say
